Pharmaceuticals · SILVER SPRING, MD, United States
$550.88
-0.63% (-$3.47)2026-07-09
Smart-Money SignalDistribution · 26/100— Insiders are net sellers over 90 days (-$321M, 914 sales vs 86 buys)
Revenue$781.5M
Net Income$274.9M
EPS$5.82
Gross Margin82.9%
Market Cap$23.2B
Price Performance
Historical data including institutional events
Company Profile
M
Martine Rothblatt
CEO & Executive Director
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.
